iBio (IBIO) Return on Capital Employed Growth (1y) (2012 - 2026)
iBio (IBIO) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 2,400.00 |
| 10 | iBio | 166.84 Mn | 166.84 Mn | - | 6,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,986.00 |
| Dec 31, 2025 | 4,094.00 |
| Sep 30, 2025 | 1,318.00 |
| Jun 30, 2025 | -7,698.00 |
| Mar 31, 2025 | -2,403.00 |
| Dec 31, 2024 | 6,044.00 |
| Sep 30, 2024 | 7,558.00 |
| Jun 30, 2024 | 9,512.00 |
| Mar 31, 2024 | 4,688.00 |
| Dec 31, 2023 | -5,728.00 |
| Sep 30, 2023 | -8,940.00 |
| Jun 30, 2023 | -10,325.00 |
| Mar 31, 2023 | -10,945.00 |
| Dec 31, 2022 | -6,477.00 |
| Sep 30, 2022 | -3,228.00 |
| Jun 30, 2022 | -1,608.00 |
| Mar 31, 2022 | -764.00 |
| Dec 31, 2021 | -582.00 |
| Sep 30, 2021 | -447.00 |
| Jun 30, 2021 | -28.00 |